| Katherine Barhorst, CNM | |
|
3440 Burnet Ave, Suite 120, Cincinnati, OH 45229-2833 | |
| (513) 751-5900 | |
| (513) 487-4590 |
| Full Name | Katherine Barhorst |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 3440 Burnet Ave, Cincinnati, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881662989 | NPI | - | NPPES |
| 200800140C | Medicaid | IN | |
| 2204064 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | CNM9913 (Ohio) | Primary |
| Entity Name | Bethesda Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598710881 PECOS PAC ID: 3476456997 Enrollment ID: O20040130000688 |
News Archive
'Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem' aims to highlight the significant roles of inflammation in head and neck malignancy.
Postnova Analytics reports on the extended data available through integrating its AF2000 MultiFlow Flow Field-Flow Fractionation (FFF) platform with its SC2000 modular multi-detector Size Exclusion chromatography (SEC) system.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.
How cells regulate their own function by "accelerating and braking" is important basic knowledge when new intelligent medicines are being developed, or when plant cells are tweaked to produce more bioenergy.
› Verified 4 days ago
| Entity Name | Trihealth H Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811215742 PECOS PAC ID: 1850570458 Enrollment ID: O20110128000356 |
News Archive
'Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem' aims to highlight the significant roles of inflammation in head and neck malignancy.
Postnova Analytics reports on the extended data available through integrating its AF2000 MultiFlow Flow Field-Flow Fractionation (FFF) platform with its SC2000 modular multi-detector Size Exclusion chromatography (SEC) system.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.
How cells regulate their own function by "accelerating and braking" is important basic knowledge when new intelligent medicines are being developed, or when plant cells are tweaked to produce more bioenergy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Barhorst, CNM Po Box 633370, Cincinnati, OH 45263-3370 Ph: (513) 891-8630 | Katherine Barhorst, CNM 3440 Burnet Ave, Suite 120, Cincinnati, OH 45229-2833 Ph: (513) 751-5900 |
News Archive
'Head and Neck Cancer: Hallmarks of The Inflammation Ecosystem' aims to highlight the significant roles of inflammation in head and neck malignancy.
Postnova Analytics reports on the extended data available through integrating its AF2000 MultiFlow Flow Field-Flow Fractionation (FFF) platform with its SC2000 modular multi-detector Size Exclusion chromatography (SEC) system.
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.
How cells regulate their own function by "accelerating and braking" is important basic knowledge when new intelligent medicines are being developed, or when plant cells are tweaked to produce more bioenergy.
› Verified 4 days ago
Mrs. Meryll Guillory Thomas-langford, APRN.CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3219 Clifton Ave Ste 210, Cincinnati, OH 45220 Phone: 513-751-5900 | |
Leah A. Terhune, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4244 Hamilton Ave, Cincinnati, OH 45223 Phone: 513-681-4900 Fax: 513-853-8432 | |
Donna O Patno, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3333 Burnet Ave, Cincinnati, OH 45229 Phone: 513-636-9608 | |
Ms. Nancy Lynn Baron, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3440 Burnet Ave, Ste. 120, Cincinnati, OH 45229 Phone: 513-751-5900 Fax: 513-487-4590 | |
Deena Jo Parsons, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3440 Burnet Ave, Suite 120, Cincinnati, OH 45229 Phone: 513-751-5900 Fax: 513-487-4590 | |
Mrs. Andrea Chipps, CNM, APRN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3440 Burnet Ave, Cincinnati, OH 45229 Phone: 513-751-5900 | |
Sapphira Champange Pranger, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3219 Clifton Ave Ste 210, Cincinnati, OH 45220 Phone: 513-751-5900 Fax: 513-487-4590 |